Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis

被引：0
|
作者：
Bradley A. Warady
Eric Ng
Laura Bloss
May Mo
Franz Schaefer
Justine Bacchetta
机构：
[1] Children’s Mercy Kansas City,Division of Pediatric Nephrology
[2] Amgen Inc.,undefined
[3] Heidelberg University Hospital,undefined
[4] Department of Pediatric Nephrology,undefined
[5] Rheumatology and Dermatology,undefined
[6] Femme Mère Enfant Hospital,undefined
来源：
Pediatric Nephrology | 2020年 / 35卷
关键词：
Cinacalcet; CKD-MBD; Dialysis; Pediatric; sHPT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1679 / 1697
页数：18
相关论文
共 50 条
  • [1] Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
    Warady, Bradley A.
    Ng, Eric
    Bloss, Laura
    Mo, May
    Schaefer, Franz
    Bacchetta, Justine
    PEDIATRIC NEPHROLOGY, 2020, 35 (09) : 1679 - 1697
  • [2] Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis
    Diez, Juan J.
    Miguel, Jose Luis
    Codoceo, Rosa
    Iglesias, Pedro
    Bajo, M. Auxiliadora
    Sanchez, Carmen
    del Peso, Gloria
    Gil, Fernando
    Martinez-Ara, Jorge
    Gancedo, Pilar Gonzalez
    Selgas, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) : 1387 - 1395
  • [3] Cinacalcet: A new treatment for secondary hyperparathyroidism in patients receiving hemodialysis
    Byrnes, CA
    Shepler, BM
    PHARMACOTHERAPY, 2005, 25 (05): : 709 - 716
  • [4] Cinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice
    Bover, Jordi
    Perez, Rafael
    Molina, Manuel
    Benavides, Beatriz
    Ariza, Francisco
    Luis Miguel, Jose
    Tornero, Fernando
    Vicens Torregrosa, Josep
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C109 - C121
  • [5] Cinacalcet Treatment in Dialysis Patients with Secondary Hyperparathyroidism: Effects and Open Issues
    Drueeke, Tilman B.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 : S2 - S12
  • [6] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Irene Ruderman
    Edward R. Smith
    Nigel D. Toussaint
    Tim D. Hewitson
    Stephen G. Holt
    BMC Nephrology, 19
  • [7] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Ruderman, Irene
    Smith, Edward R.
    Toussaint, Nigel D.
    Hewitson, Tim D.
    Holt, Stephen G.
    BMC NEPHROLOGY, 2018, 19
  • [8] An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
    Malluche, H. H.
    Monier-Faugere, M. -C.
    Wang, G.
    Frazao, J. M.
    Charytan, C.
    Coburn, J. W.
    Coyne, D. W.
    Kaplan, M. R.
    Baker, N.
    McCary, L. C.
    Turner, S. A.
    Goodman, W. G.
    CLINICAL NEPHROLOGY, 2008, 69 (04) : 269 - 278
  • [9] A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
    Warady, Bradley A.
    Iles, Janet N.
    Ariceta, Gema
    Dehmel, Bastian
    Hidalgo, Guillermo
    Jiang, Xun
    Laskin, Benjamin
    Shahinfar, Shahnaz
    Vande Walle, Johan
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2019, 34 (03) : 475 - 486
  • [10] A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
    Bradley A. Warady
    Janet N. Iles
    Gema Ariceta
    Bastian Dehmel
    Guillermo Hidalgo
    Xun Jiang
    Benjamin Laskin
    Shahnaz Shahinfar
    Johan Vande Walle
    Franz Schaefer
    Pediatric Nephrology, 2019, 34 : 475 - 486
12345